The useful thing about a long career is not that it supplies a larger collection of business cards. It is that patterns begin to reveal themselves. In Leo Tarkovsky’s case, the pattern is integration. Put the consumer specialists beside the professional marketers. Connect the strategic thinkers to the makers. Give a client a clear door into a complicated company. Now, at Decera Clinical, connect a fast-moving body of scientific evidence to the people expected to act on it.
Tarkovsky has worked inside three of the great holding-company systems - IPG, WPP and Publicis - and later inside a fast-growing independent. His route has taken him through Grey, Publicis, J. Walter Thompson, McCann Health, WPP and Fingerpaint Group. The names change; the assignment keeps rhyming. A business has plenty of expertise, spread across plenty of rooms, and somebody has to make the whole place behave like one company.
In January 2025, that assignment brought him to Clinical Education Alliance as chief executive. By the end of that year, the company had become Decera Clinical, with accredited education, healthcare-professional insights and medical communications gathered under one identity. Rebrands can be expensive ways to replace stationery. This one attached a new name to an operating argument: scientific discovery has accelerated, but the path from evidence to everyday practice has become crowded, noisy and difficult to navigate.
“Are we adding to the noise, or helping them find the signal?”Leo Tarkovsky, on clinical communications
An operator who keeps finding the walls
Tarkovsky arrived at McCann HumanCare in 2013 to lead a 42-person consumer health agency in North America. The inherited operation had strong digital work and recognizable pharmaceutical clients. He saw a broader possibility. The agency began pitching beyond the conventional pharmaceutical brief, pursuing retailers, hospitals, health systems and pharmacy-related work. By 2016, the business had reached its highest revenue level since its founding.
Growth was only half the story. Consumer health marketing and communications aimed at healthcare professionals had often lived in parallel lanes, even when a client’s problem crossed both. Tarkovsky helped bring those disciplines together in New York. By 2017 he was leading the combined McCann Health New York operation. A former creative partner later recalled that the consumer business grew to nearly three times its earlier size and credited the combination of HCP and direct-to-consumer capabilities as an important part of what followed.
The work was commercial, but it made room for creative ambition. During his McCann presidency, Tarkovsky appeared in the credits for campaigns ranging from the Mucinex character Mr. Mucus to The Unfinished Votes, a gun-safety project that received The One Show’s 2021 Best of Discipline honor in personalized digital. Leaders do not make every frame or write every line, and campaign credits are crowded for good reason. Their less visible job is to build the conditions in which specialists can produce coherent work together.
That distinction matters in an industry fond of assigning a single name to a collective result. Tarkovsky’s record is not the tale of a lone strategist descending with a perfect diagram. It is a record of teams, assembled and rearranged so that creative, commercial, medical and digital specialists can see the same problem. The executive skill is architectural. Decide which doors should connect, remove a few unnecessary corridors, and resist the natural corporate urge to build a reception desk for every discipline.
His colleagues’ descriptions add some texture to the org chart. One called him “high energy and low drama,” a rare combination in an industry that has never lacked for either energy or drama, though seldom in the proper proportions. Another remembered the strategic guidance, the calm and the willingness to combine practices rather than defend their borders. These are recommendations, not neutral character studies, but they match the decisions visible in his career.
A chance to build, not merely administer
After seven years at McCann and a global healthcare growth role at WPP, Tarkovsky made an instructive move. In 2022, he joined Fingerpaint Group as its first chief commercial officer. Fingerpaint was an independent network expanding through acquisitions. It had accumulated an impressive range of commercialization services. The next task was to connect them.
He described the attraction with unusual directness: “I just couldn’t pass up a chance to build and scale something extraordinary.” He also knew the person he would report to, global president Bill McEllen, from their overlapping years at McCann. Familiarity mattered, but so did the contrast. Tarkovsky had spent much of his career in giant holding companies. Fingerpaint offered the chance to apply that platform-level experience inside a younger, independent structure that was still deciding what it would become.
His language at Fingerpaint centered on the client’s route through the organization. The group, he said, should function as a portal or gateway to talent and capabilities. That is a subtle correction to the usual agency sales pitch. A long menu of services may impress during a presentation, but it can become exhausting once the work begins. Clients do not want to conduct the orchestra from the stalls. They want a partner who knows which players should enter and when.
“Our approach is to position our group as a portal, as a gateway to the best talent, the best capabilities.”Leo Tarkovsky, at Fingerpaint Group
By 2024, he was talking less about a roster of capabilities and more about the quality of partnership: senior attention, empathy and people who cared about the brand and the people affected by it. The philosophy sounds soft until one notices its hard commercial purpose. A client buys expertise once. A client returns because the expertise is accessible, coordinated and pleasant to work with.
A career built around connecting the pieces
Learning the machinery of global agency networks.
Growing a consumer agency, then integrating consumer and professional disciplines.
Coordinating global healthcare growth across companies and disciplines.
Helping an acquisitive independent turn many services into one client gateway.
Uniting education, insights and communications around evidence-to-action.
The scarce product is not information
Decera presents a different version of the same organizational puzzle. Its education division traces its roots through established continuing-education brands. Its insights work draws on direct access to practicing clinicians. Its communications business helps life sciences companies shape scientific narratives and tools. Each can stand on its own. Tarkovsky’s bet is that they become more valuable when their feedback loops touch.
A clinician’s response to an educational program can reveal where understanding breaks down. That insight can improve the next communication strategy. A clearer scientific narrative can strengthen the next educational experience. The loop matters because healthcare professionals are not waiting in a quiet room for the next elegant slide deck. They are sorting through new evidence while managing crowded schedules and consequential decisions.
Decera calls the distance between new science and its use in practice the Scientific Activation gap. The phrase is branded, but the problem is plain. Information is abundant. Attention, context and trust are scarce. At the company’s 2025 market debut, Tarkovsky put it more bluntly: clinicians are “drowning in data and promotional noise,” and filtering aggressively.
Scale makes the question sharper. Decera says its accredited education operation generates millions of learning engagements each year and works across more than 20 specialties. Those numbers confer reach, not automatic relevance. A company that publishes at scale can close a knowledge gap or simply add another layer to the pile. Tarkovsky’s recent distinction between signal and noise is therefore more than a tidy quotation. It is a useful standard by which his strategy can be judged.
The ambition hiding inside clarity
Tarkovsky’s public manner is that of an operator rather than a celebrity executive. His statements return to growth, partnership, capabilities and the practical work of joining them. Even the grander Decera vocabulary lands on a modest human behavior: someone understands a piece of evidence well enough to do something useful with it.
That modesty disguises a sizable ambition. Decera works with life sciences companies around the world and reaches clinicians across many specialties. It advises organizations whose therapies and products sit inside dense scientific and regulatory environments. Making that system clearer requires more than good copy. It requires credible experts, careful education, real-world feedback, useful technology and the restraint to leave irrelevant material out.
The career arc now looks almost suspiciously neat. At McCann, separate audiences needed one operation. At Fingerpaint, acquired capabilities needed one gateway. At Decera, evidence, insight and communication need one path toward action. Tarkovsky has spent decades finding the walls inside organizations. His current work asks whether he can also shorten the distance between what science knows and what practice can absorb.
There will always be another channel, another data set and another impressive capability to add to the brochure. The more difficult choice is deciding what belongs together and what the audience actually needs. In that sense, Tarkovsky’s cleanest question applies to his own long record as much as it applies to medical communications: does the structure create more noise, or does it help people find the signal?